Clinical Trial Update: Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer

View source ↗

Summary

Non-interventional study evaluating nivolumab with or without ipilimumab in adults with advanced renal cell carcinoma; status is Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Renal Cell Carcinoma, Renal Cell Cancer | Status: ACTIVE_NOT_RECRUITING